Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trial
The Lancet Respiratory Medicine (2021) - Comments
doi: 10.1016/s2213-2600(21)00377-5  issn: 2213-2600  pubmed: 34756178  issn: 2213-2619 

Jozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Cedric Bosteels, Simon J Tavernier, Stefanie De Buyser, Roos Colman, Maya Hites, Gil Verschelden, Tom Fivez, Filip Moerman, Ingel K Demedts, Nicolas Dauby, Nicolas De Schryver, Elke Govaerts, Stefaan J Vandecasteele, Johan Van Laethem, Sebastien Anguille, Jeroen Van Der Hilst